C A Ridgeway1, T J Hieken, S G Ronan
1Department of Surgical Oncology, University of Illinois at Chicago.
Acral lentiginous melanoma (ALM) does not independently impact patient outcomes. Tumor thickness, not histologic subtype, is the key prognostic factor for survival in melanoma patients.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: